205 related articles for article (PubMed ID: 24726456)
1. Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells.
David M; Naudin C; Letourneur M; Polrot M; Renoir JM; Lazar V; Dessen P; Roche S; Bertoglio J; Pierre J
Mol Oncol; 2014 Jul; 8(5):942-55. PubMed ID: 24726456
[TBL] [Abstract][Full Text] [Related]
2. High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.
Li C; Bu J; Liao Y; Zhang J; Han J; Zhang H; Xing H; Li Z; Wu H; Liang L; Wang M; Qin W; Yang T
Cell Physiol Biochem; 2018; 51(6):2829-2842. PubMed ID: 30562757
[TBL] [Abstract][Full Text] [Related]
3. Physcion inhibits the metastatic potential of human colorectal cancer SW620 cells in vitro by suppressing the transcription factor SOX2.
Han YT; Chen XH; Gao H; Ye JL; Wang CB
Acta Pharmacol Sin; 2016 Feb; 37(2):264-75. PubMed ID: 26707141
[TBL] [Abstract][Full Text] [Related]
4. Tumour-promoting role of SOCS1 in colorectal cancer cells.
Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
[TBL] [Abstract][Full Text] [Related]
5. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
7. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
8. REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer.
Zeng YT; Liu XF; Yang WT; Zheng PS
Oncogene; 2019 Oct; 38(43):6940-6957. PubMed ID: 31409905
[TBL] [Abstract][Full Text] [Related]
9. MLLT10 promotes tumor migration, invasion, and metastasis in human colorectal cancer.
Jing X; Wu H; Cheng X; Chen X; Zhang Y; Shi M; Zhang T; Wang X; Zhao R
Scand J Gastroenterol; 2018 Aug; 53(8):964-971. PubMed ID: 30102091
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of suppressors of cytokine signaling 1 inhibition of epithelial-mesenchymal transition signaling through ROS regulation in colon cancer cells: suppression of Src leading to thioredoxin up-regulation.
Jung SH; Kim SM; Lee CE
Oncotarget; 2016 Sep; 7(38):62559-62571. PubMed ID: 27613835
[TBL] [Abstract][Full Text] [Related]
11. SOCS1 Represses Fractionated Ionizing Radiation-Induced EMT Signaling Pathways through the Counter-Regulation of ROS-Scavenging and ROS-Generating Systems.
Kim S; Kim SH; Lee CE
Cell Physiol Biochem; 2020 Oct; 54(5):1026-1040. PubMed ID: 33048478
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
[TBL] [Abstract][Full Text] [Related]
13. MiR-150 alleviates EMT and cell invasion of colorectal cancer through targeting Gli1.
Fan H; Liu X; Zheng WW; Zhuang ZH; Wang CD
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4853-4859. PubMed ID: 29164577
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.
Gui Y; Khan MGM; Bobbala D; Dubois C; Ramanathan S; Saucier C; Ilangumaran S
World J Gastroenterol; 2017 Sep; 23(36):6639-6649. PubMed ID: 29085209
[TBL] [Abstract][Full Text] [Related]
15. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
16. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
Xin H; Wang C; Liu Z
BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression.
Paterson EL; Kazenwadel J; Bert AG; Khew-Goodall Y; Ruszkiewicz A; Goodall GJ
Neoplasia; 2013 Feb; 15(2):180-91. PubMed ID: 23441132
[TBL] [Abstract][Full Text] [Related]
18. MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras.
Fang Y; Sun B; Li Z; Chen Z; Xiang J
Mol Carcinog; 2016 Sep; 55(9):1369-77. PubMed ID: 26333174
[TBL] [Abstract][Full Text] [Related]
19. KSR1- and ERK-dependent translational regulation of the epithelial-to-mesenchymal transition.
Rao C; Frodyma DE; Southekal S; Svoboda RA; Black AR; Guda C; Mizutani T; Clevers H; Johnson KR; Fisher KW; Lewis RE
Elife; 2021 May; 10():. PubMed ID: 33970103
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
